People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Somatus, Inc. | — | Other Health Care | Series C | $140.1M | $1.1B | 2018 |
| Positive Development, Inc. | — | Other | Series B | $72.2M | $119.8M | 2022 |
Daniel Gebremedhin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Gebremedhin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Anna Haghgooie | 1 | 11 |
| Brenton Fargnoli | 1 | 7 |
| John Banta | 1 | 6 |
| Julian Harris | 1 | 6 |
| Mark Pacala | 1 | 5 |
| Adam Seabrook | 1 | 5 |
| Roy Beveridge | 1 | 4 |
| Eric Larsen | 1 | 4 |
| Dan Gebremedhin | 1 | 3 |
| Greg Grunberg | 1 | 3 |
| Andy Slavitt | 1 | 3 |
| Anthony Welters | 1 | 2 |
| Mike Suiters | 1 | 1 |
| Ikenna Okezie | 1 | 1 |
| Paul Weisbruch | 1 | 1 |
| Jon Kunkle | 1 | 1 |
| James Santry | 1 | 1 |
| Andrew Slavitt | 1 | 1 |
| Alexander Houlday | 1 | 1 |
| Stacey Queen-Pyndell | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.